
Jun 23, 2025, 12:40
A New Era in Hemophilia A Prophylaxis: Dr. Shima Presented Groundbreaking Phase I/II Results for NXT007
NXT007 Hemophilia A Prophylaxis took center stage today when Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on X.
“A New Era in Haemophilia A Prophylaxis. Dr. Shima presented groundbreaking phase I/II results for NXT007, a next-generation bispecific antibody: 30 patients with severe haemophilia A (no inhibitors), age range: 12-65 years (median age 39.5 years), subcutaneous dosing: 0.072-1.08 mg/kg every 4 weeks.
Higher dose cohorts (B-3, B-4) achieved FVIII-equivalent activity in the normal range.
Well-tolerated profile with no thromboembolic events, but high anti-drug antibody prevalence: 22/30 patients (73%) and effect on plasma concentrations in 2/22.”
Stay up to date with Hemostasis Today
-
Jun 23, 2025, 12:41Tissue Factor as a Prognostic Marker in Acute PE: Time for Clinical Trials?
-
Jun 23, 2025, 12:40A New Era in Hemophilia A Prophylaxis: Dr. Shima Presented Groundbreaking Phase I/II Results for NXT007
-
Jun 23, 2025, 11:54Synovitis in Hemophilia: Prognostic Biomarkers Could Guide Future Therapy
-
Jun 23, 2025, 11:26VEXAS Syndrome Research by Pierre Sujobert Awarded by HemaSphere
-
Jun 23, 2025, 11:22Riten Kumar Shared New ISTH Data: 3-Month Apixaban Course Shows Better Safety Profile Than Rivaroxaban in Acute VTE
-
Jun 23, 2025, 13:27Gunnar Henrik Heine: Apixaban Substantially Safer than Rivaroxan for Initial Treatment of VTE
-
Jun 23, 2025, 12:35Cardiac Manifestations in Glycogen Storage Diseases: Insights from Nature Reviews Cardiology
-
Jun 23, 2025, 12:02Brian O Mahony: Nice illustration on Haemophilia Gene Therapy by George at ISTH2025
-
Jun 22, 2025, 12:53Kristen Sanfilippo: Time to Anticoagulants Therapy is a Modifiable Risk Factor for PE-associated Mortality
-
Jun 22, 2025, 09:42Tara Lech: Treatment of VTE Does NOT End at Discharge!
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 22, 2025, 11:27The ISTH Congress Daily News Team Interviews Rob Montgomery
-
Jun 22, 2025, 07:54Flora Peyvandi: Congratulations to Robert Montgomery! Thanks For All Your Work For Our Society
-
Jun 21, 2025, 20:12Flora Peyvandi: Thanks, Claire, for All You Have Done for the Women and Early Career Members of the ISTH
-
Jun 21, 2025, 18:11Thomas Reiser: Welcome to ISTH2025
-
Jun 21, 2025, 12:22Ayesha But: Headed to ISTH Congress 2025!
Jun 23, 2025, 12:41
Jun 23, 2025, 11:54
Jun 23, 2025, 11:26
Jun 23, 2025, 11:18
Jun 22, 2025, 12:35